← Back to Search

Polyphenol Supplement

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

N/A
Waitlist Available
Led By Jeffrey S Bland, Ph.D
Research Sponsored by Big Bold Health, PBC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a polyphenol-rich dietary supplement on 50 patients to see if it can improve immune health over a few months.

Eligible Conditions
  • Aging
  • Inflammation
  • Autoimmune diseases
  • Inflammation and Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Epigenetic immune age
Secondary study objectives
Leukocyte profiling

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HTB RejuvenateExperimental Treatment1 Intervention
4 capsules of study interventional supplement delivered as 2 capsules two times a day for 90 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HTB Rejuvenate
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Big Bold Health, PBCLead Sponsor
TruDiagnosticIndustry Sponsor
11 Previous Clinical Trials
436 Total Patients Enrolled
8 Trials studying Aging
326 Patients Enrolled for Aging
Austin D Perlmutter, MDStudy DirectorBig Bold Health
~14 spots leftby Dec 2025